You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid

Showing 1 - 25 of 6,879
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Frequency and Risk Factors of Acute Myeloid Leukemia

    Not yet recruiting
    • Myeloid Leukemia
    • Bone marrow aspirite for diagnosis
    • (no location specified)
    Mar 15, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Mitoxantrone hydrochloride liposome injection
      • +3 more
      • (no location specified)
      May 29, 2023

      Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

      Recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 23, 2023

      Acute Myeloid Leukemia Trial in Taipei

      Enrolling by invitation
      • Acute Myeloid Leukemia
        • Taipei, Taiwan
          National Taiwan University Hospital
        Aug 9, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 1, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • Hetrombopag Olamine
        • (no location specified)
        Jul 5, 2023

        PET Tracer Based FDG Signal for Predicting Prognosis in Acute

        Enrolling by invitation
        • Acute Myeloid Leukemia
        • No intervention
        • Guangzhou, Guangdong, China
          First Affiliated Hospital of Jinan University
        Jun 22, 2023

        Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Yuan Kong
        Sep 4, 2023

        Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

        Recruiting
        • Acute Myeloid Leukemia
        • Suzhou, Jiangsu, China
          Qiu Huiying
        Mar 28, 2023

        GilteRInf 2022 Study (Gilteritinib Related Infections)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Roma, RM, Italy
          Maria Ilaria Del Principe
        Mar 17, 2023

        Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

        Recruiting
        • Relapsed/Refractory Acute Myeloid Leukemia
        • B7-H3 target, CAR gene modified gdT cell injection
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital， Zhejiang University School of Med
        Feb 15, 2023

        Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Minimal Residual Disease
          • Chapel Hill, North Carolina
            North Carolina Cancer Hospital (NCCH)
          Feb 2, 2023

          Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

          Recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • CD123 targeted CAR-NK cells
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Aug 28, 2023

          Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

          Recruiting
          • Leukemia, Myeloid, Acute
          • Chengdu, Sichuan, China
            West China Hospital of Sichuan University
          Dec 27, 2022

          Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

          Recruiting
          • Refractory/Relapse Acute Myeloid Leukemia
          • Kunming, Yunnan, China
            Department of Hematology,920th Hospital of Joint Logistic Suppor
          Mar 28, 2023

          Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

          Recruiting
          • Acute Myeloid Leukemia
          • CIML-NK Cells
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Jan 4, 2023

          Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Dec 13, 2022

          Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

          Recruiting
          • Acute Myeloid Leukemia
          • +2 more
          • Miami, Florida
            University of Miami
          Dec 22, 2022

          Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +5 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          AML Trial in Guanzhou (CLAG)

          Not yet recruiting
          • AML
          • CLAG
          • Guanzhou, Guangdong, China
          • +1 more
          May 16, 2023

          Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • High-Risk and Very High-Risk Myelodysplastic Syndromes
          • (no location specified)
          Jul 25, 2023

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

          Recruiting
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +6 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 31, 2022